WO2023042081 - )-4-SUBSTITUTED CYCLOHEXANE-1-AMINES

National phase entry:
Publication Number WO/2023/042081
Publication Date 23.03.2023
International Application No. PCT/IB2022/058641
International Filing Date 14.09.2022
Title **
[English] )-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
[French] )-4
Applicants **
RICHTER GEDEON NYRT. Gyömröi út 19-21. 1103 Budapest, HU
BUDAPESTI MŰSZAKI ÉS GAZDASÁGTUDOMÁNYI EGYETEM Műegyetem rkp. 3. 1111 Budapest, HU
Inventors
FARKAS, Emese Kossuth út 109. 3841 Aszaló, HU
POPPE, László Szilasliget utca 3. 1172 Budapest, HU
HORNYÁNSZKY, Gábor Szárny u. 7. 1173 Budapest, HU
INCZE, Dániel János Kresz Géza utca 44-46. III/24 1132 Budapest, HU
ÉLES, János Ördögszikla út 2. 1121 Budapest, HU
SÁNTA-BELL, Evelin Bártfai u. 36. 8/26 1115 Budapest, HU
MOLNÁR, Zsófia Klára Kovász u. 12. 1238 Budapest, HU
SZEMES, József      Juhász Gyula u. 27/A 2315 Szigethalom, HU
SCHNEIDER, Anna Szilágyi Erzsébet u. 9. 8900 Zalaegerszeg, HU
CSUKA, Pál       Hunyadi u. 79. 2085 Pilisvörösvár, HU
Priority Data
P2100325   15.09.2021   HU
P2200363   13.09.2022   HU
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
Sequence Listing *
International Search Report is established
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing2668
EPO Filing, Examination21746
Japan Filing558
South Korea Filing611
USA Filing, Examination16235
MasterCard Visa

Total: 41818

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] -4-((1,3-dioxolan-2-yl)methyl)cyclohexan-1-amine may be produced.[French] -4-((1,3-dioxolan-2-yl)méthyl)cyclohexane-1-amine.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙